naion glp-1 medicine and non-arteritic anterior ischemic optic neuropathy: Literature review and perspectives GLP-1 medications and eye problem

No serious adverse events, clinically significant cardiovascular effects, or mutagenic, teratogenic, or fertility-related risks have been reported, supporting its favorable safety profile, including in pediatric populations (Verlaet et al., 2017)

doi: 10.1080/09546634.2020.1826392 Summary Keywords glucagon-like peptide-1, liraglutide, inflammatory diseases, immunomodulation, signal pathways Citation Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X and Zhong J (2022) GLP-1 receptor agonist as a modulator of innate immunity

Available from: Tracey ML, Li-Fen L, Cindy L, Shen L, John M, Homero R, et al

doi: 10.3390/medicina57101030 34 MaesMTwiskFNM